Irving, TEXAS5 Active Studies

Advanced Solid Tumors Clinical Trials in Irving, TEXAS

Find 5 actively recruiting advanced solid tumors clinical trials in Irving, TEXAS. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,209
Enrolling

Recruiting Advanced Solid Tumors Studies in Irving

RecruitingIrving, TEXASNCT06334432

Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

NUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors. The Phase 1 portion include patients with advanced solid...

466 participants
Nuvation Bio Inc.
View Study Details
RecruitingIrving, TEXASNCT06914128

A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors

The study treatment, BAY 3713372, is under development to treat MTAP (methylthioadenosine phosphorylase)-deleted solid tumors. It is thought to work by blocking the protein arginine N-methyltransferas...

370 participants
Bayer
View Study Details
RecruitingIrving, TEXASNCT04905914

Study Of ATRN-119 In Patients With Advanced Solid Tumors

The purpose of this study is to assess the safety and effectiveness of ATRN-119 through the performance of a Phase 1/2a, open-label, safety, PK, and preliminary efficacy study of oral ATRN-119 in pati...

132 participants
Aprea Therapeutics
View Study Details
RecruitingIrving, TEXASNCT06657222

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030. The main questions it aims to answer are: To ...

130 participants
Tubulis GmbH
View Study Details
RecruitingIrving, TEXASNCT06028074

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

GIM-122 is a first-in-class, humanized immunoglobulin G1 kappa dual functioning monoclonal antibody (DFA). This phase 1 / 2 study plans to evaluate the safety, tolerability, pharmacokinetics and clini...

111 participants
Georgiamune Inc
View Study Details

About Advanced Solid Tumors Clinical Trials in Irving

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 5 advanced solid tumors clinical trials recruiting participants in Irving, TEXAS. These studies are seeking a combined 1,209 participants. Research is being sponsored by Nuvation Bio Inc., Bayer, Aprea Therapeutics and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Irving — FAQ

Are there advanced solid tumors clinical trials in Irving?

Yes, there are 5 advanced solid tumors clinical trials currently recruiting in Irving, TEXAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Irving?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Irving research site will contact you about next steps.

Are clinical trials in Irving free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Irving studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 5 active trials in Irving are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov